Production (Stage)
Stoke Therapeutics, Inc.
STOK
$9.43
$0.252.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.09% | 7.70% | 11.40% | 21.83% | -29.60% |
| Total Receivables | 5,409.09% | 993.75% | 619.79% | 124.26% | -97.76% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.39% | -1.79% | -10.05% | -5.53% | 5.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.06% | 57.75% | -9.02% | 17.92% | -32.64% |
| Total Current Assets | 94.40% | 8.09% | 10.26% | 20.62% | -28.48% |
|
|
|||||
| Total Current Assets | 94.40% | 8.09% | 10.26% | 20.62% | -28.48% |
| Net Property, Plant & Equipment | -34.36% | -33.62% | -0.43% | 1.49% | 3.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 26.71% | 26.71% | -13.18% | -13.18% | 0.00% |
| Total Assets | 98.31% | 18.92% | 22.27% | 19.79% | -27.19% |
|
|
|||||
| Total Accounts Payable | 4.00% | 47.37% | -19.21% | 153.53% | -51.10% |
| Total Accrued Expenses | 112.33% | 42.18% | 23.54% | 23.34% | -13.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.24% | 12.61% | -8.01% | -7.06% | -7.95% |
| Total Finance Division Other Current Liabilities | -7.58% | 22.13% | 249.83% | 209.15% | 56.90% |
| Total Other Current Liabilities | -7.58% | 22.13% | 249.83% | 209.15% | 56.90% |
| Total Current Liabilities | 25.55% | 29.97% | 97.87% | 103.76% | 12.89% |
|
|
|||||
| Total Current Liabilities | 25.55% | 29.97% | 97.87% | 103.76% | 12.89% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -54.88% | -48.63% | 267.28% | 142.89% | 96.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -59.13% | -99.92% | -79.61% | -60.85% | -26.86% |
| Total Liabilities | -12.38% | -38.16% | -8.50% | -2.51% | -4.61% |
|
|
|||||
| Common Stock & APIC | 28.06% | 28.24% | 29.97% | 28.79% | 6.45% |
| Retained Earnings | 11.74% | -22.14% | -28.13% | -29.56% | -33.95% |
| Treasury Stock & Other | -- | -529.17% | 212.93% | 96.04% | -- |
| Total Common Equity | 149.44% | 43.53% | 34.17% | 27.61% | -34.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 149.44% | 43.53% | 34.17% | 27.61% | -34.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 149.44% | 43.53% | 34.17% | 27.61% | -34.37% |
|
|
|||||